HRP20190315T1 - Uporaba tiazolo pirimidinona radi liječenja upalnih bolesti crijeva - Google Patents

Uporaba tiazolo pirimidinona radi liječenja upalnih bolesti crijeva

Info

Publication number
HRP20190315T1
HRP20190315T1 HRP20190315TT HRP20190315T HRP20190315T1 HR P20190315 T1 HRP20190315 T1 HR P20190315T1 HR P20190315T T HRP20190315T T HR P20190315TT HR P20190315 T HRP20190315 T HR P20190315T HR P20190315 T1 HRP20190315 T1 HR P20190315T1
Authority
HR
Croatia
Prior art keywords
pirimidinone
tiazolo
treat inflammation
inflammation
treat
Prior art date
Application number
HRP20190315TT
Other languages
English (en)
Croatian (hr)
Inventor
Chaitanya Dutt
Vijay Chauthaiwale
Ram Gupta
Shitalkumar ZAMBAD
Shailesh Deshpande
Jignesh Kotecha
Ramesh Gupta
Sanjay Srivastava
Laxmikant Chhipa
Jaya Abraham
Original Assignee
Torrent Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Limited filed Critical Torrent Pharmaceuticals Limited
Publication of HRP20190315T1 publication Critical patent/HRP20190315T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
HRP20190315TT 2013-05-14 2014-05-12 Uporaba tiazolo pirimidinona radi liječenja upalnih bolesti crijeva HRP20190315T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1718MU2013 2013-05-14
IN2309MU2013 2013-07-09
PCT/IB2014/000707 WO2014184631A1 (en) 2013-05-14 2014-05-12 Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease
EP14728622.3A EP2996693B1 (en) 2013-05-14 2014-05-12 Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
HRP20190315T1 true HRP20190315T1 (hr) 2019-04-05

Family

ID=50896342

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20190315TT HRP20190315T1 (hr) 2013-05-14 2014-05-12 Uporaba tiazolo pirimidinona radi liječenja upalnih bolesti crijeva

Country Status (28)

Country Link
US (2) US9610247B2 (https=)
EP (1) EP2996693B1 (https=)
JP (1) JP6407974B2 (https=)
KR (1) KR102239649B1 (https=)
CN (1) CN105209043B (https=)
AU (1) AU2014266968B2 (https=)
BR (1) BR112015028581B1 (https=)
CA (1) CA2912011C (https=)
CY (1) CY1121280T1 (https=)
DK (1) DK2996693T3 (https=)
EA (1) EA030590B1 (https=)
ES (1) ES2712705T3 (https=)
HR (1) HRP20190315T1 (https=)
HU (1) HUE042691T2 (https=)
IL (1) IL242490B (https=)
LT (1) LT2996693T (https=)
MX (1) MX358198B (https=)
MY (1) MY179215A (https=)
PH (1) PH12015502560B1 (https=)
PL (1) PL2996693T3 (https=)
PT (1) PT2996693T (https=)
RS (1) RS58423B1 (https=)
SG (1) SG11201509275PA (https=)
SI (1) SI2996693T1 (https=)
SM (1) SMT201900111T1 (https=)
TW (1) TWI661828B (https=)
UA (1) UA117244C2 (https=)
WO (1) WO2014184631A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11324829B2 (en) * 2016-03-14 2022-05-10 Santen Pharmaceutical Co., Ltd. Antiseptic agent comprising meglumine or salt thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8962530B2 (en) * 2007-06-27 2015-02-24 Regents Of The University Of Colorado Inflammatory bowel disease therapies
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮
US8541430B2 (en) * 2009-11-27 2013-09-24 Torrent Pharmaceuticals Limited Fused thiazolo and oxazolo pyrimidinones

Also Published As

Publication number Publication date
CN105209043B (zh) 2019-07-02
ES2712705T3 (es) 2019-05-14
HUE042691T2 (hu) 2019-07-29
US10471005B2 (en) 2019-11-12
KR102239649B1 (ko) 2021-04-12
SG11201509275PA (en) 2015-12-30
SI2996693T1 (sl) 2019-04-30
AU2014266968B2 (en) 2019-09-19
TW201513866A (zh) 2015-04-16
RS58423B1 (sr) 2019-04-30
MX358198B (es) 2018-08-08
MY179215A (en) 2020-11-02
NZ714098A (en) 2020-12-18
DK2996693T3 (en) 2019-03-18
PL2996693T3 (pl) 2019-05-31
JP2016518440A (ja) 2016-06-23
SMT201900111T1 (it) 2019-02-28
WO2014184631A1 (en) 2014-11-20
LT2996693T (lt) 2019-03-12
EP2996693B1 (en) 2018-12-12
PT2996693T (pt) 2019-02-27
US20170157129A1 (en) 2017-06-08
US20160120801A1 (en) 2016-05-05
EP2996693A1 (en) 2016-03-23
PH12015502560A1 (en) 2016-02-22
AU2014266968A1 (en) 2015-12-03
JP6407974B2 (ja) 2018-10-17
US9610247B2 (en) 2017-04-04
PH12015502560B1 (en) 2016-02-22
BR112015028581B1 (pt) 2022-05-03
CN105209043A (zh) 2015-12-30
CA2912011C (en) 2021-10-26
CY1121280T1 (el) 2020-05-29
EA201592159A1 (ru) 2016-04-29
IL242490B (en) 2018-11-29
TWI661828B (zh) 2019-06-11
UA117244C2 (uk) 2018-07-10
CA2912011A1 (en) 2014-11-20
MX2015015682A (es) 2016-07-20
EA030590B1 (ru) 2018-08-31
BR112015028581A2 (pt) 2017-07-25
KR20160008571A (ko) 2016-01-22

Similar Documents

Publication Publication Date Title
DK2875743T3 (da) Kittel
LT3290407T (lt) Bromodomeno inhibitoriai
EP2969007A4 (en) HISTONE DEMETHYLASE INHIBITORS
BR302013003730S1 (pt) Configuração aplicada em tigela
LT3038654T (lt) Naujas panaudojimas
PL3563837T3 (pl) Terapia bakteriofagami
EP2977381A4 (en) TERPENOIDDERIVAT
DK2976101T3 (da) Behandlingsfremgangsmåde
HUE060237T2 (hu) Szedoheptulóz alkalmazása gyulladás megelõzésére vagy kezelésére
HRP20190315T1 (hr) Uporaba tiazolo pirimidinona radi liječenja upalnih bolesti crijeva
DK3041506T3 (da) Behandlingsfremgangsmåde
UA28912S (uk) Гайка
UA28682S (uk) Гайка
UA28676S (uk) Гайка
UA28651S (uk) Гайка
UA28650S (uk) Гайка
UA28652S (uk) Гайка
UA25887S (uk) Гайка
UA26659S (uk) Гайка
UA26345S (uk) Гайка
UA26344S (uk) Гайка
UA26343S (uk) Гайка
UA25774S (uk) Гайка
UA25885S (uk) Гайка
UA26281S (uk) Гайка